Skip to content
Abierto

Award notice, first published as presolicitation

Levetiracetam Tablets

36E79726R0001

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

Awarded

Xlcare Pharmaceuticals Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of November 12, 2025.

Page 2 of 2 Amendment to Extend Due Date and Time for Offers This amendment is issued to extend the due date and time for receipt of offers submitted in response to solicitation 36E79726R0001 for Levetiracetam Tablets from 11/26/2025 to 12/03/2026 at 2:30PM Central Time. All other solicitation terms and conditions remain unchanged. Offerors shall include a completed and signed copy of the amendment with their proposal.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
MEAUS5WHBJJ7
CAGE
86SL9
Vendor location
Lawrenceville, GA
Contract
36E79726D0019
Obligated
$0.00, potential $9,568,741
Actions
2 between February 5, 2026 and August 31, 2026
Competition
Full and Open Competition, 5 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Levetiracetam Tablets with Xlcare Pharmaceuticals. Ordering Period Feb 5, 2026 to May 23, 2026, with Four ONE-YEAR Options.
Match
award number 36E79726D0019 equals the contract number; same awarding office 36E797 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 21, 2025

    Presolicitation

    Due November 24, 2025 at 3:30 PM EST. SAM.gov, notice 3a742ade17a545ee8ebabfea44af9aee

  2. November 12, 2025

    Solicitation, originally presolicitation

    Due November 26, 2025 at 3:30 PM EST. SAM.gov, notice 424dd3bd99834ef08ccbf9cc7899aa26

  3. November 12, 2025

    Solicitation

    Due December 3, 2025 at 3:30 PM EST. SAM.gov, notice 967978e634764957a58815703ce3a2ba

  4. February 11, 2026

    Award notice

    Awarded to Xlcare Pharmaceuticals Inc. Lawrenceville 30046 for $9,568,741. SAM.gov, notice 78926691bed0445dbbe5248722361b7b

Points of contact